Blackstone’s BioMed Realty to double UK life sciences portfolio

The Blackstone portfolio company, BioMed Realty, has announced plans to double its life sciences holdings in the UK through two strategic deals in Cambridge.

Premium subscriber content – please log in to read more or take a free trial.


Latest news

Best read stories